An Open-label Study to Evaluate the Long-term Safety and Efficacy of CSL312 (Garadacimab) in the Prophylactic Treatment of Hereditary Angioedema

Project: Research

Project Details

StatusFinished
Effective start/end date12/08/21 → 31/12/23

Keywords

  • Hereditary angioedema
  • Clinical trial